Magazine article from our research archive:

Not good enough: Some feel FDA's easing of off-label rules still falls short

Some feel

FDA's easing

of off-label

rules still

falls short

Too little, too late. That's how critics of the Food & Drug Administration view the agency's proposal to ease its restrictions against promoting offlabel uses. Under recently released draft policy guidelines, the FDA would let pharmaceutical manufacturers distribute peer-reviewed journal articles and medical textbooks that contain incidental, nonhighlighted references to off-label uses. But the plan so far has failed to attract enthusiastic support.

"The FDA's action indicates that it continues to believe that doctors cannot be trusted to make appropriate use of truthful medical information," said Richard A. Samp, chief counsel ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!